In addition, Hcy/CRP were significantly associated with L-dopa dosage for both PD and VP patients (P<0.001, Table 6), and Hcy/CRP were correlated with H&Y (P<0.01, Table 6) in PD patients. Here, CRP is linked to Parkinson disease.